Current therapeutic strategies in glomerulonephritis

Annals of the Academy of Medicine Singapore

Volumn 28, Issue 2, 1999, Pages 272-278

  Woo, K T ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Course; Nephritis; Prognosis; Rationale; Treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS; WARFARIN;

ARTICLE; DRUG RESISTANCE; FOCAL GLOMERULONEPHRITIS; GLOMERULONEPHRITIS; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHRITIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN RESTRICTION; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RENOVASCULAR HYPERTENSION; STEROID THERAPY; WEGENER GRANULOMATOSIS;

EID: 0033038773     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cameron J S. The clinical significance of glomerular permeability studies. Proc R Soc Med 1966; 59:512-5.
2. Woo K T, Wu A Y T, Lau Y K, Lee E J C, Edmondson R P S, Pwee H S, et al. Protein selectivity in IgA nephropathy. Nephron 1986; 42:236-9.
3. Woo K T, Lau Y K, Yap H K, Lee G S L, Chiang G S C, Lim C H. Protein selectivity: A prognostic in IgA nephritis. Nephron 1989; 52:300-6.
4. Collaborative study of the adult idiopathic nephrotic syndrome: a controlled study of short-term treatment in adults with membranous nephropathy. N Engl J Med 1979; 301:1301-6.
5. Cattran D C, Delmore T, Roscoe J. A randomised controlled trial of prednisolone in patients with idiopathic membranous nephropathy. N Engl J Med 1989; 320:210-5.
6. Briggs W A, Choi M J, Scheel P J Jr. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 1998; 31:213-7.
7. Danoff T M, Neilson E G. The role of chemo-attractants in renal disease. In: Neilson E G, Couser W G, editors. Immunologic Renal Diseases. Philadelphia, New York: Lippincott-Raven, 1997:499-517.
8. Cameron J S. Treatment of primary glomerulonephritis using immunosuppressive agents. Am J Nephrol 1989; 9(Suppl 1):33-40.
9. Broyer M, Meyrier A, Niaudet P, Habib R. Minimal changes and focal segmental glomerular sclerosis. In: Cameron J S, Davison A M, Grunfeld Y P, Ken D, Ritz E, editors. Oxford Textbook of Clinical Nephrology. Oxford: Oxford Univ Press, 1992:298-339.
10. Brenner B M, Meyer T W, Hostetter T H. Dietary protein and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982; 307:652-9.
11. Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant 1994; 9:265-9.
12. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 1994; 45:537-43.
13. Anderson S, Rennke H G, Brenner B M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77:1993-2000.
14. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa Y. Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989; 36:26-35.
15. Diamond J R, Karnovsky M J. Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 1988; 33:917-24.
16. Woo K T, Lee G S L, Lau Y K, Chiang G S C, Lim C H. Effects of triple therapy in IgA nephritis: A follow up study 5 years later. Clin Nephrol 1991; 36:60-6.
17. Glassock R J, Adler S A, Ward H J, Cohen A H. Primary glomerular diseases. In: Brenner B M, Rector F C, editors. The Kidney. Philadelphia: W B Saunders Co, 1991:1182-279.
18. Singhal P C, Malik G H, Narayan G, Khan A S, Bhusnurmath S, Datta B N, et al. Prognosis of post-streptococcal glomerulonephritis: Chandigarh Study. Ann Acad Med Singapore 1982; 11:36-41.
19. Barker G J. Nephrotic syndrome in adults - Principles of management. In: Yap H K, Tan C C, Woo K T, editors. Proceedings of the 11th Asian Colloquium in Nephrology. Singapore: Armour Publishing, 1996:235-40.
20. Shalhoub R J. Pathogenesis of lipoid nephrosis: A disorder of T cell function. Lancet 1974; 2:556-60.
21. Woo K T. Nephrotic syndrome. In: Clinical Nephrology. Singapore: World Scientific Publishing and Singapore University Press, 1998:57-81.
22. Waldher R, Gubler M C, Levy M, Broyer M, Habib R. The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol 1978; 10:171-9.
23. D'Amico G. Focal segmental glomerulosclerosis (FSGS) revisited. In: Yap H K, Tan C C, Woo K T, editors. Proceedings of the 11th Asian Colloquium in Nephrology. Singapore: Armour Publishing, 1996:227-34.
24. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, et al. A 10 year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48:1600-4.
25. McCauley J, Shapiro R, Ellis D, Igdal H, T Zakis A, Starzl T E. Pilot trial of FK 506 in the managementof steroid resistant nephrotic syndrome. Nephrol Dial Transplant 1993; 8:1286-90.
26. Cameron J S. The long term outcome of glomerular diseases. In : Schrier R N, Gottschalk C V, editors. Diseases of the Kidney. London: Little Brown & Co, 1992:1895-958.
27. Haas M, Spargo B H, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study. Am J Kidney Dis 1995; 26:740-50.
28. Rydel J J, Korbet S M, Borok R Z, Schwartz M M. Focal segmental glomerular sclerosis in adults : Presentation, course, and response to treatment. Am J Kidney Dis 1995; 25:534-42.
29. Cameron J S. The problem of focal segmental glomerulosclerosis. In: Kincaid-Smith P, d'Apice A J F, Atkins R, editors. Progress in Glomerulonephritis. New York: John Wiley and Sons, 1979:209-28.
30. Beaufils H, Alphonse J C, Guedon J, Legain M. Focal global sclerosis: Natural history and treatment. A report of 70 cases. Nephron 1978; 21:75-85.
31. Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 1991; 36:53-9.
32. McEnery P T, McAdams A J, West C D. Membranoproliferative glomerulonephritis: improved survival with alternate day prednisolone therapy. Clin Nephrol 1980; 13:117-24.
33. Kincaid-Smith P. The natural history and treatment of mesangiocapillary glomerulonephritis. Morphology, natural history and treatment. Part I. New York: John Wiley and Sons, 1973:591-609.
34. Davis C A, McEnery P T, Maby S, McAdams A J, West C D. Observations on the evolution of rapidly progressive glomerulonephritis. Clin Nephrol 1978; 9:91-102.
35. Woo K T, Edmondson R P S, Wu A Y T, Chiang G S C, Pwee H S, Lim C H. The natural history of IgA nephritis in Singapore. Clin Nephrol 1986; 25:15-21.
36. D'Amico G. Epidemiology, clinical and prognostic indices in IgA nephropathy. Nephrology 1997; 3:13-7.
37. Woo K T. Treatment of IgA nephropathy in Singapore. Nephrology 1997; 3:S731-3.
38. Woo K T, Edmondson R P S, Yap H K, Wu A Y T, Chiang G S C, Lee E J C, et al. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 1987; 27:56-64.
39. Lee G S L, Woo K T, Lim C H. Controlled trial of dipyridamole and low dose warfarin in patients with IgA nephritis with renal impairment. Clin Nephrol 1989; 31:276.
40. Woo K T, Lau Y K, Wong K S, Chin Y M, Chiang G S C, Lim C H. Isoelectric focussing and protein selectivity index as predictors of response to therapy in IgA nephrotic syndrome. Nephron 1994; 67:408-13.
41. Bohle A, Mackensen-Haen S, von Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: A morphometric contribution. Am J Nephrol 1987; 7:421-33.